NIMG-36. THE SIGNIFICANCE OF PUNCTATE CONTRAST-ENHANCING LESIONS IN TREATED HIGH GRADE GLIOMA

NIMG-36. 治疗后高级别胶质瘤中点状增强病灶的意义

阅读:2

Abstract

We report on a series of nine patients with high grade glioma (HGG) who developed punctate contrast-enhancing foci on MRI, several years after tumor treatment. The lesions were considered suspicious for tumor progression at their onset, but were proven over time to be benign in nature. Five of the patients were treated for glioblastoma; 3 for anaplastic astrocytoma, and one for anaplastic oligodendroglioma. Median age of the patients at diagnosis was 48 years (31–62 years). The mean time of onset of “suspicious spots” following treatment was 51 months after diagnosis (6–170 months). Of note, median overall survival of the group is 96 months; with none of the nine patients deceased, and only 2 patients known to have progression. The remainder of the 7 patients are free of active tumor and being followed off treatment. No apparent clinical manifestations of the lesions have been observed. The majority of the punctate lesions were of a dynamic nature; they appeared and spontaneously disappeared over time, without intervention. All lesions developed within the field of radiation treatment; some were contralateral to the tumor. Radiological characteristics of the lesions including analysis of SWI, DWI, and DCE magnetic resonance imaging sequences will be reported. Punctate enhancing foci in the region of radiation treatment are phenomena which may be manifestation of delayed treatment sequelae in HGG. Patients with these lesions are on average of younger age and have a particularly long survival. These lesions appeared several years following oncological treatment. The foci should be initially followed more closely until shown to be of a non-progressive nature; they should not be presumed to be indicative of tumor recurrence. Possible etiology of the lesions may be related to vascular changes induced by radiation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。